U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C11H12N2OS2
Molecular Weight 252.356
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MORPHOLINYLMERCAPTOBENZOTHIAZOLE

SMILES

C1CN(CCO1)SC2=NC3=C(S2)C=CC=C3

InChI

InChIKey=MHKLKWCYGIBEQF-UHFFFAOYSA-N
InChI=1S/C11H12N2OS2/c1-2-4-10-9(3-1)12-11(15-10)16-13-5-7-14-8-6-13/h1-4H,5-8H2

HIDE SMILES / InChI

Description
Curator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/3180764 and https://www.smartpracticecanada.com/spcanada/pdfs/all-allergens/RC294.pdf

Morpholinylmercaptobenzothiazole is a chemical allergen, it is used in the vulcanization of rubber. It is used for diagnosis of contact allergy. It is a component of Mercapto Mix, used in the epicutaneous patch test, called T.R.U.E. TEST, approved by FDA in 1994. T.R.U.E. TEST is indicated for use as an aid in the diagnosis of allergic contact dermatitis in persons 18 years of age and older whose history suggests sensitivity to one or more of the 35 substances included on the T.R.U.E. TEST panels.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
T.R.U.E. TEST

Approved Use

T.R.U.E. TEST is an epicutaneous patch test indicated for use as an aid in the diagnosis of allergic contact dermatitis in persons 18 years of age and older whose history suggests sensitivity to one or more of the 35 substances included on the T.R.U.E. TEST panels.

Launch Date

7.5712319E11
PubMed

PubMed

TitleDatePubMed
Patents

Patents

Sample Use Guides

Apply the three adhesive panels of allergens and allergen mixes on healthy skin of the back. Remove panels and evaluate the skin 48 hours after application. Re-evaluate the skin 72 to 96 hours after application.
Route of Administration: Topical
In Vitro Use Guide
Unknown
Name Type Language
MORPHOLINYLMERCAPTOBENZOTHIAZOLE
Systematic Name English
N-OXYDIETHYLENE-2-BENZOTHIAZYLSULFENAMIDE
Common Name English
SULFENAMIDE M
Brand Name English
NSC-70078
Code English
N-(OXYDIETHYLENE)BENZOTHIAZOLE-2-SULFENAMIDE
Common Name English
MORPHOLINYLMERCAPTO-BENZO-THIAZOLE
Systematic Name English
4-(1,3-BENZOTHIAZOL-2-YLSULFANYL)MORPHOLINE
Systematic Name English
2-(4-MORPHOLINO)THIOBENZOTHIAZOLE [HSDB]
Common Name English
ACCEL NS
Brand Name English
MERAMID M
Brand Name English
2-(4-MORPHOLINO)THIOBENZOTHIAZOLE
HSDB  
Common Name English
Classification Tree Code System Code
NDF-RT N0000185508
Created by admin on Fri Dec 15 15:36:33 UTC 2023 , Edited by admin on Fri Dec 15 15:36:33 UTC 2023
Code System Code Type Description
NSC
70078
Created by admin on Fri Dec 15 15:36:33 UTC 2023 , Edited by admin on Fri Dec 15 15:36:33 UTC 2023
PRIMARY
SMS_ID
100000134273
Created by admin on Fri Dec 15 15:36:33 UTC 2023 , Edited by admin on Fri Dec 15 15:36:33 UTC 2023
PRIMARY
NDF-RT
N0000171131
Created by admin on Fri Dec 15 15:36:33 UTC 2023 , Edited by admin on Fri Dec 15 15:36:33 UTC 2023
PRIMARY Allergens [Chemical/Ingredient]
NDF-RT
N0000184306
Created by admin on Fri Dec 15 15:36:33 UTC 2023 , Edited by admin on Fri Dec 15 15:36:33 UTC 2023
PRIMARY Cell-mediated Immunity [PE]
CAS
102-77-2
Created by admin on Fri Dec 15 15:36:33 UTC 2023 , Edited by admin on Fri Dec 15 15:36:33 UTC 2023
PRIMARY
EPA CompTox
DTXSID0021096
Created by admin on Fri Dec 15 15:36:33 UTC 2023 , Edited by admin on Fri Dec 15 15:36:33 UTC 2023
PRIMARY
ECHA (EC/EINECS)
203-052-4
Created by admin on Fri Dec 15 15:36:33 UTC 2023 , Edited by admin on Fri Dec 15 15:36:33 UTC 2023
PRIMARY
HSDB
2867
Created by admin on Fri Dec 15 15:36:33 UTC 2023 , Edited by admin on Fri Dec 15 15:36:33 UTC 2023
PRIMARY
FDA UNII
VCD7623F3K
Created by admin on Fri Dec 15 15:36:33 UTC 2023 , Edited by admin on Fri Dec 15 15:36:33 UTC 2023
PRIMARY
PUBCHEM
7619
Created by admin on Fri Dec 15 15:36:33 UTC 2023 , Edited by admin on Fri Dec 15 15:36:33 UTC 2023
PRIMARY
CAS
40860-79-5
Created by admin on Fri Dec 15 15:36:33 UTC 2023 , Edited by admin on Fri Dec 15 15:36:33 UTC 2023
SUPERSEDED
EVMPD
SUB61032
Created by admin on Fri Dec 15 15:36:33 UTC 2023 , Edited by admin on Fri Dec 15 15:36:33 UTC 2023
PRIMARY
DAILYMED
VCD7623F3K
Created by admin on Fri Dec 15 15:36:33 UTC 2023 , Edited by admin on Fri Dec 15 15:36:33 UTC 2023
PRIMARY
DRUG BANK
DB14202
Created by admin on Fri Dec 15 15:36:33 UTC 2023 , Edited by admin on Fri Dec 15 15:36:33 UTC 2023
PRIMARY
NDF-RT
N0000175629
Created by admin on Fri Dec 15 15:36:33 UTC 2023 , Edited by admin on Fri Dec 15 15:36:33 UTC 2023
PRIMARY Increased Histamine Release [PE]